FDA Approves Injectable Nivolumab, an Alternative to IV Infusion

🔗 Access full article via NCI Cancer Currents

The injectable form of nivolumab, called Opdivo Qvantig, is quicker and easier to give, several oncologists said, and is just as effective as the intravenous form. Injectable forms of other immunotherapies are also on the horizon.